We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

3 hedge funds and large institutions have $2.16M invested in SpringWorks Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 217 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 222 → 3 (-219)

99.54% less ownership

Funds ownership: 99.59% → 0.05% (-100%)

100% less capital invested

Capital invested by funds: $3.53B → $2.16M (-$3.52B)

100% less funds holding in top 10

Funds holding in top 10: 18 → 0 (-18)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 217

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-219
Holders Change %
-98.65%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
217
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$341M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$335M
3
GCL
Glazer Capital LLC
New York
-$193M
4
Fidelity International
Fidelity International
Bermuda
-$142M
5
State Street
State Street
Massachusetts
-$141M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
151
Cubist Systematic Strategies
Connecticut
– -$356K -7,579 Closed
CB
152
Commerce Bank
Missouri
– -$354K -7,541 Closed
AIP
153
Ameritas Investment Partners
Nebraska
– -$349K -7,428 Closed
Ameriprise
154
Ameriprise
Minnesota
– -$335K -7,131 Closed
HSBC Holdings
155
HSBC Holdings
United Kingdom
– -$332K -7,062 Closed
IA
156
IFP Advisors
Florida
– -$331K -6,859 Closed
Carson Wealth (CWM LLC)
157
Carson Wealth (CWM LLC)
Nebraska
– -$300K -6,390 Closed
FPAS
158
Focus Partners Advisor Solutions
Missouri
– -$295K -6,274 Closed
Walleye Capital
159
Walleye Capital
New York
– -$276K -5,882 Closed
X
160
Xponance
Pennsylvania
– -$265K -5,637 Closed
SEI Investments
161
SEI Investments
Pennsylvania
– -$263K -5,588 Closed
BNP Paribas Financial Markets
162
BNP Paribas Financial Markets
France
– -$257K -5,474 Closed
TRCT
163
Tower Research Capital (TRC)
New York
– -$253K -5,384 Closed
FCM
164
Farallon Capital Management
California
– -$235K -5,000 Closed
SSG
165
Summit Securities Group
New York
– -$235K -5,000 Closed
Walleye Trading
166
Walleye Trading
New York
– -$235K -5,000 Closed
SRL
167
Scientech Research LLC
New Jersey
– -$231K -4,917 Closed
American Century Companies
168
American Century Companies
Missouri
– -$231K -4,907 Closed
BAM
169
Bayshore Asset Management
Florida
– -$228K -4,852 Closed
FSA
170
Financial Security Advisor
Virginia
– -$223K -4,755 Closed
Truist Financial
171
Truist Financial
North Carolina
– -$215K -4,586 Closed
Public Employees Retirement Association of Colorado
172
Public Employees Retirement Association of Colorado
Colorado
– -$215K -4,575 Closed
GKIM
173
GW&K Investment Management
Massachusetts
– -$210K -4,478 Closed
Mackenzie Financial
174
Mackenzie Financial
Ontario, Canada
– -$207K -4,408 Closed
PNC Financial Services Group
175
PNC Financial Services Group
Pennsylvania
– -$191K -4,065 Closed
5 6
7
8 9

SWTX Hedge Fund Activity: Q3 2025 in Review

3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2025, worth a combined $2.16M — down 100% from $3.53B a quarter earlier.

Sellers outnumbered buyers: 217 funds closed out of SWTX and 0 opened new positions — a net loss of 217 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $341M sold.

  • 3 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2025, down from 222 in Q2 2025.
  • Funds reported $2.16M of SpringWorks Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new SpringWorks Therapeutics positions in Q3 2025 and 217 closed out, a net change of -217 holders.
  • The largest SpringWorks Therapeutics seller in Q3 2025 was BlackRock, an estimated $341M sold.

Based on aggregated 13F filings for Q3 2025.